How Matthew Gallagher Built Medvi Into a $401M Telehealth Company With Almost No Team

The first one-person telehealth company on a billion-dollar trajectory.

Updated 2026-04-17

Revenue

$401M (2025) → $1.8B projected (2026)

Employees

2 (Matthew Gallagher + his brother Elliot) — clinicians and fulfillment outsourced

Industry

Telehealth (GLP-1 weight loss)

Founder

Matthew Gallagher

Timeline

Early 2024Matthew Gallagher spots GLP-1 search volume exploding post-Ozempic wave. He had no healthcare background — his previous ventures were in direct-response marketing.
Mid 2024Puts $20,000 of personal savings into a direct-to-consumer GLP-1 brand built out of his house in Los Angeles. Uses ChatGPT, Claude, and Grok to draft code, marketing copy, website, and customer support scripts (publicly credited to the NYT).
September 2024Medvi launches with a single-page funnel and Stripe checkout. Doctors, prescriptions, and shipping are fully outsourced to telehealth partners CareValidate and OpenLoop.
Late 2024First wave of creator-driven paid acquisition on social and TikTok drives rapid growth. Gallagher hires his only employee — his younger brother Elliot.
Throughout 2025Scales from 300 to 250,000+ customers. Runs the entire operation as a 2-person team with AI doing the heavy lifting on creative, ops, and support triage.
December 2025FDA sends Medvi a formal warning letter citing misleading claims ('Same active ingredient as Wegovy and Ozempic') and labeling that implied Medvi was the compounder when it is not.
End of 2025Closes first full year at $401M in gross sales with a reported 16.2% net profit margin — roughly three times the margin of Hims & Hers, which had ~2,442 employees to generate 6x the revenue.
Q1 2026Featured by The New York Times as the poster child for the 'one-person billion-dollar company.' Projecting $1.8B in 2026 revenue. Lawsuits and data-breach allegations emerge in parallel with the coverage.

Key insights

  • 01Timing matters more than originality: Gallagher did not invent GLP-1 telehealth — he arrived when demand was outpacing incumbent telehealth capacity and moved faster than anyone else.
  • 02One person with AI can run the operating cadence of a ~50-person DTC brand: copywriting, compliance-adjacent content, customer ops, finance close, creator partnerships.
  • 03The real moat is not software. It is licensed medical directors, pharmacy partnerships, and the unit economics of ad-to-revenue.
  • 04Distribution beat product. Medvi's product is essentially a telehealth intake + Stripe + pharmacy API. The differentiator was media buying speed and creative volume.
  • 05Owning 100% of a one-person company at $65M of profit is structurally different from raising venture capital — Gallagher never had to optimize for anyone but himself and his patients.
  • 06Regulatory risk is the real ceiling. The scale-up phase required Medvi to mature its clinical protocols faster than a normal one-person company would.
  • 07'Boring' categories (weight loss, ED, hair loss, skincare) where prescriptions are cash-pay are the most fertile ground for a one-person DTC powerhouse in 2026.

Stack used

CareValidate and OpenLoop — outsourced telehealth infrastructure (doctors, prescriptions, e-prescribing, shipping)ChatGPT, Claude, and Grok — publicly cited by Gallagher as the AI tools behind code, copy, website, and customer serviceStripe for payments and subscription billingsocial ads + TikTok Ads with creator whitelisting and direct-response creative503A/503B compounding pharmacy relationships via telehealth partnersCustomer support autoresponder with human-in-the-loop escalationOff-the-shelf SaaS bookkeeping and reportingSingle landing-page funnel (no complex site)Affiliate / creator marketplace tools for paid partnershipsStandard analytics stack (social pixel, server-side events, dashboards)

What this means for you

  • Pick a category where demand is already screaming — do not create a market, ride one. Search Trends, Amazon top sellers, and TikTok Shop categories are the cheapest signal.
  • Outsource every regulated function to a real expert (medical directors, licensed pharmacies, CPAs). Keep AI in the general-operator seat, not the licensed-professional seat.
  • Treat creative volume as your core competence. One founder plus AI can produce more hooks, scripts, and thumbnails per week than a 5-person agency.
  • Keep ownership. Medvi shows that a boring cash-pay vertical can compound faster than any venture play — and you will not have to sell the company to realize the result.
  • Design the company so your job is capital allocation and category judgment, not execution. A good Manager + AI CMO + AI CFO setup turns your day into approving, not doing.
  • Watch the regulator. If your category has a tailwind, assume the enforcement wind is 6-12 months behind. Mature the compliance side before you are forced to.
FAQ

Frequently asked questions

Clear answers about wallet credit, usage, subscriptions, and how Tycoon charges for work.

How did Medvi reach $401M in revenue in 12 months with just two people?

Gallagher did not build a product from scratch. He combined three already-existing systems — telehealth infrastructure (CareValidate, OpenLoop), compounding pharmacies, and social/TikTok ads — and wrapped them in a single funnel optimized for GLP-1 demand. AI (ChatGPT, Claude, Grok, all publicly credited) handled the operational load that would normally require dozens of employees: code, copy, website, customer service scripts. Comparison point from the same period: Hims & Hers did ~$2.4B in revenue with 2,442 employees at a 5.5% net margin, while Medvi did $401M with 2 people at a 16.2% net margin.

Is Medvi really a 'one-person company' if it has 2 employees and outsourced partners?

Strictly speaking, no — but it is the clearest proof yet that a 2-person team with AI and outsourced licensed partners can run a multi-hundred-million-dollar operation. The clinical side (physicians, pharmacists, fulfillment) is handled by CareValidate and OpenLoop, which is the only legal path to operate in telehealth. The important shift is not the exact headcount, but the ratio: roughly 1 employee per 125,000 customers, versus one employee per ~100 customers at a traditional telehealth brand. That is the compression AI enables.

What regulatory risk does Medvi face after the FDA warning letter?

Significant. In December 2025 the FDA sent Medvi a formal warning letter citing misleading claims like 'Same active ingredient as Wegovy and Ozempic' and labeling that implied Medvi itself was the compounder when it is not. Separately, a chunk of the compounded-GLP-1 category was built on drug-shortage exemptions that are narrowing as supply normalizes. Coverage in Techdirt and HealthDataConsortium has questioned whether the NYT piece underweighted these risks. The lesson for solo founders in regulated verticals: go-to-market speed must be paired with a maturing compliance posture, or the business you built in 12 months can be legislated away in 6.

Could a non-marketer replicate Medvi's playbook today?

Partially. The most transferable parts are the operating model (AI as general operator, outsourced licensed roles, one person at the top making capital and category decisions) and the funnel pattern (narrow landing page, fast intake, subscription billing). The non-transferable part is Gallagher's decade of affiliate marketing and direct-response experience, which let him buy media profitably on day one. A non-marketer can still replicate the operating model in a category that is less CAC-driven — SaaS, info products, B2B services, or community-driven commerce.

What does Medvi tell us about the 'one-person billion-dollar company' prediction?

Medvi is the most credible real-world data point yet. Sam Altman predicted in late 2024 that we would see a one-person billion-dollar company, and Dario Amodei put his confidence for 2026 at 70-80%. Medvi does not yet cross the billion-dollar revenue line, but its 2026 projection ($1.8B) would. More importantly, it demonstrates that the bottleneck is no longer the amount of work a single founder can ship — it is the judgment calls about category, compliance, and capital allocation. That reshapes what kind of person 'founder' means in 2026.

Related resources

One-person company

Polsia: $0 to $10.4M ARR, $30M Raise, Then a Decline

Ben Cera launched Polsia Dec 2025. 8,509 autonomous companies, $10.4M ARR, $30M Series A at $250M — then ARR dropped 3% in a week. The full breakdown.

One-person company

Pieter Levels: $3M/yr Solo, 0 Employees

Pieter Levels built 70+ projects, 3 of them past $38K MRR each, solo since 2014. The original one-person company playbook.

One-person company

Solo-Founded Telehealth: The 2025-2026 Wave

Medvi isn't alone. A wave of solo-founded cash-pay telehealth brands emerged in 2025-2026. Here is the pattern.

Playbook

The One-Person Billion-Dollar Company Playbook (2026)

Sam Altman predicted it. Matthew Gallagher proved it with Medvi's $1.8B projected 2026. Here's the playbook — market, stack, execution, milestones.

Playbook

Reach $1M ARR Solo: The Playbook (2026)

The systematic path from $0 to $1M ARR as a solo founder in 2026. Category picks, stack, milestones, numbers that actually work.

Pillar

Run a One-Person Company With a Full AI Workforce (2026)

Build a one-person company with an AI workforce manager that gives you a CEO, CMO, CTO, COO, and operators. No hires, no freelancers — just you and an AI team.

Stop managing agents. Just describe outcomes.

Tycoon Agent manages all your agents. Set her up in 30 seconds, free.

Free to start · No credit card required · Set up in 30 seconds